---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-012608"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2024-02-12T23:59:59+00:00"
generated_at: "2026-06-06T04:23:45.756885+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Onconetix appoints Thomas Meier to board per Series B preferred holders' right

## Summary
- Thomas Meier, PhD appointed as Class I director, term through 2025 annual meeting.
- Meier has 25+ years biotech experience; chairs Santhera Pharmaceuticals (SIX:SANN).
- Consulting agreement: CHF 400/hr as sellers' rep (Proteomedix deal) and CHF 350/hr as advisor.
- Appointment effective Feb 6, 2024; ratified by Audit Committee Feb 8, 2024.

## SEC filing metadata
- accession: 0001213900-24-012608
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2024-02-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390024012608/0001213900-24-012608-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390024012608/ea193470-8k_onconetix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-012608
- JSON: https://secwatch.observer/filing/0001213900-24-012608.json
- Plain text: https://secwatch.observer/filing/0001213900-24-012608.txt

## Key facts
- Executive change
  Thomas Meier was appointed as Director at Onconetix, Inc..
  - Action: appointed
  - Role: Director
  source text: On February 6, 2024, pursuant to the Certificate of Designation of Series B Convertible Preferred Stock, the holders of Series B Convertible Preferred Stock appointed Thomas Meier, PhD, to the board of directors of Onconetix, Inc. (the “ Company ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782107/000121390024012608/0001213900-24-012608-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.